OBJECTIVE: In addition to staging, the identification of prognostic factors is important for predicting survival in @entity1 with @entity418 after esophagectomy. The present study was performed to document the prognostic role of total lesion glycolysis (TLG) in postoperative @entity1 . METHODS: We retrospectively reviewed the records of 50 @entity1 with @entity1721 who underwent surgical resection and complete lymph node dissection after positron emission tomography-computed tomography (PET-CT). A volume of interest was drawn on the @entity75 and suspected metastatic lymph nodes, and the maximum standardized uptake value (SUVmax), metabolic @entity5 volume (MTV), TLG of the @entity75 (TLGp), and whole-body TLG (TLGwb) were measured using an SUV cutoff of 2.5. RESULTS: The study population included 50 @entity1 with a mean age of 63.14    8.18 years: 12 (24%) were reported as stage I, 13 (26%) as stage II, and 25 (50%) as stage III. The median follow-up period was 20.46 months, and recurrences occurred in 17 @entity1 . The mean SUVmax, MTV, TLGp, and TLGwb were 11.11    6.40, 20.47    22.88, 122.54    180.98, and 129.37    193.66, respectively. On the multivariate analysis, TLGp was a risk factor for @entity66 ( @entity66 ) [hazard ratio (HR) = 1.002, p = 0.026], and TLGwb was a risk factor for @entity66 (HR = 1.002, p = 0.021) and @entity1349 ( @entity1349 ) (HR = 1.002, p = 0.044). The 3-year @entity1349 rates were 66.1% in @entity1 with low TLGwb (<=  41.45) and 33.3% in those with high TLGwb (>41.45; p = 0.004). The concordance index of the TLGwb was 0.752 (95% CI 0.659-0.845). CONCLUSION: TLGwb is a significant prognostic factor for @entity1349 and @entity66 in @entity1 with surgically treated @entity1721 .

The prognostic value of total lesion glycolysis via 18F-fluorodeoxyglucose PET-CT in surgically treated XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity66 :: ('MESH:D004194', 'Disease') :: ['DFS', 'disease-free survival'] @entity75 :: ('MESH:D001927', 'Disease') :: ['primary lesion'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity1721 :: ('MESH:C562729', 'Disease') :: ['esophageal squamous cell carcinoma'] @entity418 :: ('MESH:D004938', 'Disease') :: ['esophageal cancer'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity1721 :: (MESH:C562729,Disease) :: ['esophageal squamous cell carcinoma']
